Compare Lustrum:D.Western Therapeutics Institute, Inc.:4576

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index D.Western Therapeutics Institute, Inc. Go to web site 4576 Medicals 東証グロース December 1, 2000 2009.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

D.Western Therapeutics Institute, Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

D.Western Therapeutics Institute, Inc. Balance Sheet 2024年12月期 D.Western Therapeutics Institute, Inc. Balance Sheet 2023年12月期 D.Western Therapeutics Institute, Inc. Balance Sheet 2022年12月期 D.Western Therapeutics Institute, Inc. Balance Sheet 2021年12月期 D.Western Therapeutics Institute, Inc. Balance Sheet 2020年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents
(Percent)
1,126down
(67.4%)down
1,867down
(78.7%)down
2,335up
(79.0%)up
1,934down
(78.5%)down
2,308
(84.3%)
Other Current AssetsHelp
(Percent)
349up
(20.9%)up
271down
(11.4%)up
324up
(11.0%)up
228up
(9.3%)up
195
(7.1%)
Tangible Fixed AssetsHelp
(Percent)
11up
(0.7%)up
10down
(0.4%)up
10up
(0.3%)up
5down
(0.2%)down
5
(0.2%)
Intangible Fixed AssetHelp
(Percent)
44down
(2.7%)down
87down
(3.6%)down
125down
(4.2%)down
167down
(6.8%)down
208
(7.6%)
Investments and OthersHelp
(Percent)
138down
(8.3%)up
139down
(5.9%)up
163up
(5.5%)up
129up
(5.3%)up
21
(0.8%)
Total AssetsHelp
(Percent)
1,669
(100%)
2,373
(100%)
2,956
(100%)
2,463
(100%)
2,738
(100%)
Total Current LiabilitiesHelp
(Percent)
157down
(9.4%)up
218down
(9.2%)up
251up
(8.5%)down
245up
(10.0%)up
234
(8.5%)
Total Long-term LiabilitiesHelp
(Percent)
779down
(46.7%)up
876up
(36.9%)up
848up
(28.7%)up
210down
(8.5%)down
340
(12.4%)
Shareholder's EquityHelp
(Percent)
734down
(44.0%)down
1,280down
(53.9%)down
1,857down
(62.8%)down
2,007down
(81.5%)up
2,164
(79.0%)
Total LiabilitiesHelp
(Percent)
1,669
(100%)
2,373
(100%)
2,956
(100%)
2,463
(100%)
2,738
(100%)

D.Western Therapeutics Institute, Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

D.Western Therapeutics Institute, Inc. Profit and Loss Account 2024年12月期 D.Western Therapeutics Institute, Inc. Profit and Loss Account 2023年12月期 D.Western Therapeutics Institute, Inc. Profit and Loss Account 2022年12月期 D.Western Therapeutics Institute, Inc. Profit and Loss Account 2021年12月期 D.Western Therapeutics Institute, Inc. Profit and Loss Account 2020年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales
(Percent)
472
(100%)
428
(100%)
448
(100%)
414
(100%)
356
(100%)
Total Sales
(Percent)
472
(100%)
428
(100%)
448
(100%)
414
(100%)
356
(100%)
Cost of SalesHelp
(Percent)
47up
(9.9%)up
37up
(8.6%)up
28up
(6.2%)up
20up
(4.8%)up
17
(4.8%)
Other Costs and RevenueHelp 1,715up
(363.7%)up
1,204up
(281.1%)up
850up
(189.7%)up
543down
(131.1%)down
615
(172.9%)
Total CostsHelp 1,762 1,241 878 563 632
Net RevenueHelp 425up
(90.1%)down
392down
(91.4%)down
421up
(93.8%)down
394up
(95.2%)down
339
(95.2%)
Earnings Before TaxHelp -1,289down
(-273.3%)down
-827down
(-193.0%)down
-440down
(-98.3%)down
-160up
(-38.5%)up
-290
(-81.4%)
Net IncomeHelp -1,290down
(-273.6%)down
-812down
(-189.7%)down
-430down
(-95.9%)down
-149up
(-36.0%)up
-276
(-77.6%)
当期純利益 -1,290 -812 -430 -149 -276

D.Western Therapeutics Institute, Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

D.Western Therapeutics Institute, Inc. Cash Flow Statement 2024年12月期 D.Western Therapeutics Institute, Inc. Cash Flow Statement 2023年12月期 D.Western Therapeutics Institute, Inc. Cash Flow Statement 2022年12月期 D.Western Therapeutics Institute, Inc. Cash Flow Statement 2021年12月期 D.Western Therapeutics Institute, Inc. Cash Flow Statement 2020年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
-1,299down
(-99.2%)down
-587down
(-97.5%)down
-355down
(-39.6%)up
-176up
(-45.0%)down
-216
(-21.5%)
Investing Cash Flow(ICF)Help
(Percent)
-10up
(-0.8%)up
-15up
(-2.5%)up
-140down
(-15.6%)up
-111down
(-28.4%)down
-13
(-1.3%)
Financing Cash FlowHelp
(Percent)
568up
(43.4%)up
134down
(22.3%)down
867up
(96.8%)up
-104down
(-26.7%)down
1,004
(100.0%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0up
(0.0%)down
0down
(0.0%)down
28up
(3.2%)down
17up
(4.5%)up
-7
(-0.7%)
Net Increase and Decrease in Cash and Cash Equivalentsn -741down
(-56.6%)up
-467down
(-77.6%)down
401up
(44.8%)up
-374down
(-95.5%)down
767
(76.4%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

D.Western Therapeutics Institute, Inc.
TOHOKUSHINSHA FILM CORPORATION

Company where related level is highHelp

SANTEN PHARMACEUTICAL CO.,LTD.
ASKA Pharmaceutical Holdings Co., Ltd.
CHUKYOIYAKUHIN CO.,LTD.
TOWA PHARMACEUTICAL CO.,LTD.
ROHTO PHARMACEUTICAL CO.,LTD.
KAINOS Laboratories,Inc.
Nissui Pharmaceutical Co.,Ltd.
Takeda Pharmaceutical Company Limited
DENKA SEIKEN Co.,Ltd.
Perseus Proteomics Inc.